Source: ERS Summit on priorities in respiratory medicine 2011



Rating:

Share or cite this content

Citations should be made in the following way:
P. De Boer (Amersfoort, Netherlands), M. Rutgers (Amersfoort, Netherlands). Role of patients. ERS Summit on priorities in respiratory medicine 2011

Member's Comments

No comment yet.

Related content which might interest you: Role of MSC in lung-transplanted patients Source: Research Seminar 2014 - The many faces of stem cells in respiratory diseases Year: 2014 Role of antioxidant in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001 Role of interleukin-2 for patients with tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 647s Year: 2004 PP108 – Role of TRIM-16-mediated lysophagy in COPD pathogenesis Source: ERS Lung Science Conference 2021 Year: 2021 Experience of olokizumab use in COVID-19 patients Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 Assessment of sympathetic activity in OSA patients and healthy subjects: Effects of treatment Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness Year: 2010 Evaluation of 38 patients with Poland‘s syndrome Source: Annual Congress 2010 - Congenital lesions and rare pathology Year: 2010 Evaluation of 57 patients with Poland‘s syndrome Source: Annual Congress 2009 - Pleural problems, congenital lesions and novel technical devices Year: 2009 Role of the surgeon Source: International Congress 2016 – CC7 How to deal with large airways problems Year: 2016 Importance of fatigue measurement in sarcoidosis patients Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011 Role of bronchiectasis in alpha1-antitrypsin deficiency patients: a comparative analysis Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 Diagnostic role of the cough profile in COVID-19 patients Source: Virtual Congress 2021 – E-health for COVID-19 Year: 2021 Secretion management in neuromuscular patients Source: School Course 2014 - Noninvasive ventilation: basic concepts Year: 2014 Assessment of cardiac involvement in patients with sarcoidosis Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Role and management of COPD concomitant disorders Source: Annual Congress 2010 - GOLD Update Year: 2010 Effect of intravenous alpha-1-antitrypsin augmentation therapy on proteinase-3-generated AaVal541 in deficient patients Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Impact Prognostic impact of comorbidities in patients with chronic Hypersensitivity Pneumonitis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Role of ivermectin in hospitalized patients with mild to moderate COVID-19. Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 Management of frequently exacerbating patients Source: Eur Respir Monogr 2018; 81: 300-311 Year: 2018 Impact of COVID-19 on patients with chronic lung disease Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021